-+ 0.00%
-+ 0.00%
-+ 0.00%

ACTUATE ANNOUNCES PROMISING PRECLINICAL DATA SHOWING SYNERGISTIC ACTIVITY OF ELRAGLUSIB IN COMBINATION WITH RAS INHIBITORS ZOLDONRASIB AND DARAXONRASIB

路透·09/09/2026 11:05:31

登錄查看新聞詳情